Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. / Thomsen, Anna F.; Jøns, Christian; Jabbari, Reza; Jacobsen, Mia R.; Stampe, Niels Kjær; Butt, Jawad H.; Olsen, Niels Thue; Kelbæk, Henning; Torp-Pedersen, Christian; Fosbøl, Emil L.; Pedersen, Frants; Køber, Lars; Engstrøm, Thomas; Jacobsen, Peter Karl.

I: Europace, Bind 25, Nr. 3, 2023, s. 931-939.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Thomsen, AF, Jøns, C, Jabbari, R, Jacobsen, MR, Stampe, NK, Butt, JH, Olsen, NT, Kelbæk, H, Torp-Pedersen, C, Fosbøl, EL, Pedersen, F, Køber, L, Engstrøm, T & Jacobsen, PK 2023, 'Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status', Europace, bind 25, nr. 3, s. 931-939. https://doi.org/10.1093/europace/euac242

APA

Thomsen, A. F., Jøns, C., Jabbari, R., Jacobsen, M. R., Stampe, N. K., Butt, J. H., Olsen, N. T., Kelbæk, H., Torp-Pedersen, C., Fosbøl, E. L., Pedersen, F., Køber, L., Engstrøm, T., & Jacobsen, P. K. (2023). Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. Europace, 25(3), 931-939. https://doi.org/10.1093/europace/euac242

Vancouver

Thomsen AF, Jøns C, Jabbari R, Jacobsen MR, Stampe NK, Butt JH o.a. Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. Europace. 2023;25(3):931-939. https://doi.org/10.1093/europace/euac242

Author

Thomsen, Anna F. ; Jøns, Christian ; Jabbari, Reza ; Jacobsen, Mia R. ; Stampe, Niels Kjær ; Butt, Jawad H. ; Olsen, Niels Thue ; Kelbæk, Henning ; Torp-Pedersen, Christian ; Fosbøl, Emil L. ; Pedersen, Frants ; Køber, Lars ; Engstrøm, Thomas ; Jacobsen, Peter Karl. / Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. I: Europace. 2023 ; Bind 25, Nr. 3. s. 931-939.

Bibtex

@article{76430db21ee84532b2509d6117de68fa,
title = "Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status",
abstract = "AIMS: Emerging data show that complete revascularization (CR) reduces cardiovascular death and recurrent myocardial infarction in ST-segment elevation myocardial infarction (STEMI). However, the influence of revascularization status on development of arrhythmia in the long-term post-STEMI phase is poorly described. We hypothesized that incomplete revascularization (ICR) compared with CR in STEMI is associated with an increased long-term risk of new-onset arrhythmia. METHODS AND RESULTS: Patients with STEMI treated with primary percutaneous coronary intervention (PPCI) at Copenhagen University Hospital, Rigshospitalet, Denmark, with CR or ICR were identified via the Eastern Danish Heart registry from 2009 to 2016. Using unique Danish administrative registries, the outcomes were assessed. The primary outcome was new-onset arrhythmia defined as a composite of atrial fibrillation/flutter (AF), sinoatrial block, advanced second- or third-degree atrioventricular block, ventricular tachycardia/fibrillation (VT), or cardiac arrest (CA), with presentation >7 days post-PPCI. Secondary outcomes were the components of the primary outcome and all-cause mortality. A total of 5103 patients (median age: 62.0 years; 76% men) were included, of whom 4009 (79%) and 1094 (21%) patients underwent CR and ICR, respectively. Compared with CR, ICR was associated with a higher risk of new-onset arrhythmia [hazard ratio (HR), 1.33; 95% confidence interval (CI), 1.07-1.66; P = 0.01], AF (HR, 1.29; 95% CI, 1.00-1.66; P = 0.05), a combined outcome of VT and CA (HR, 1.77; 95% CI, 1.10-2.84; P = 0.02) and all-cause mortality (HR, 1.27; 95% CI, 1.05-1.53; P = 0.01). All HRs adjusted. CONCLUSION: Among patients with STEMI, ICR was associated with an increased long-term risk of new-onset arrhythmia and all-cause mortality compared with CR.",
keywords = "All-cause mortality, Cardiac arrhythmia, Complete revascularization, Ischaemic heart disease, Percutaneous coronary intervention",
author = "Thomsen, {Anna F.} and Christian J{\o}ns and Reza Jabbari and Jacobsen, {Mia R.} and Stampe, {Niels Kj{\ae}r} and Butt, {Jawad H.} and Olsen, {Niels Thue} and Henning Kelb{\ae}k and Christian Torp-Pedersen and Fosb{\o}l, {Emil L.} and Frants Pedersen and Lars K{\o}ber and Thomas Engstr{\o}m and Jacobsen, {Peter Karl}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.",
year = "2023",
doi = "10.1093/europace/euac242",
language = "English",
volume = "25",
pages = "931--939",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - JOUR

T1 - Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status

AU - Thomsen, Anna F.

AU - Jøns, Christian

AU - Jabbari, Reza

AU - Jacobsen, Mia R.

AU - Stampe, Niels Kjær

AU - Butt, Jawad H.

AU - Olsen, Niels Thue

AU - Kelbæk, Henning

AU - Torp-Pedersen, Christian

AU - Fosbøl, Emil L.

AU - Pedersen, Frants

AU - Køber, Lars

AU - Engstrøm, Thomas

AU - Jacobsen, Peter Karl

N1 - Publisher Copyright: © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2023

Y1 - 2023

N2 - AIMS: Emerging data show that complete revascularization (CR) reduces cardiovascular death and recurrent myocardial infarction in ST-segment elevation myocardial infarction (STEMI). However, the influence of revascularization status on development of arrhythmia in the long-term post-STEMI phase is poorly described. We hypothesized that incomplete revascularization (ICR) compared with CR in STEMI is associated with an increased long-term risk of new-onset arrhythmia. METHODS AND RESULTS: Patients with STEMI treated with primary percutaneous coronary intervention (PPCI) at Copenhagen University Hospital, Rigshospitalet, Denmark, with CR or ICR were identified via the Eastern Danish Heart registry from 2009 to 2016. Using unique Danish administrative registries, the outcomes were assessed. The primary outcome was new-onset arrhythmia defined as a composite of atrial fibrillation/flutter (AF), sinoatrial block, advanced second- or third-degree atrioventricular block, ventricular tachycardia/fibrillation (VT), or cardiac arrest (CA), with presentation >7 days post-PPCI. Secondary outcomes were the components of the primary outcome and all-cause mortality. A total of 5103 patients (median age: 62.0 years; 76% men) were included, of whom 4009 (79%) and 1094 (21%) patients underwent CR and ICR, respectively. Compared with CR, ICR was associated with a higher risk of new-onset arrhythmia [hazard ratio (HR), 1.33; 95% confidence interval (CI), 1.07-1.66; P = 0.01], AF (HR, 1.29; 95% CI, 1.00-1.66; P = 0.05), a combined outcome of VT and CA (HR, 1.77; 95% CI, 1.10-2.84; P = 0.02) and all-cause mortality (HR, 1.27; 95% CI, 1.05-1.53; P = 0.01). All HRs adjusted. CONCLUSION: Among patients with STEMI, ICR was associated with an increased long-term risk of new-onset arrhythmia and all-cause mortality compared with CR.

AB - AIMS: Emerging data show that complete revascularization (CR) reduces cardiovascular death and recurrent myocardial infarction in ST-segment elevation myocardial infarction (STEMI). However, the influence of revascularization status on development of arrhythmia in the long-term post-STEMI phase is poorly described. We hypothesized that incomplete revascularization (ICR) compared with CR in STEMI is associated with an increased long-term risk of new-onset arrhythmia. METHODS AND RESULTS: Patients with STEMI treated with primary percutaneous coronary intervention (PPCI) at Copenhagen University Hospital, Rigshospitalet, Denmark, with CR or ICR were identified via the Eastern Danish Heart registry from 2009 to 2016. Using unique Danish administrative registries, the outcomes were assessed. The primary outcome was new-onset arrhythmia defined as a composite of atrial fibrillation/flutter (AF), sinoatrial block, advanced second- or third-degree atrioventricular block, ventricular tachycardia/fibrillation (VT), or cardiac arrest (CA), with presentation >7 days post-PPCI. Secondary outcomes were the components of the primary outcome and all-cause mortality. A total of 5103 patients (median age: 62.0 years; 76% men) were included, of whom 4009 (79%) and 1094 (21%) patients underwent CR and ICR, respectively. Compared with CR, ICR was associated with a higher risk of new-onset arrhythmia [hazard ratio (HR), 1.33; 95% confidence interval (CI), 1.07-1.66; P = 0.01], AF (HR, 1.29; 95% CI, 1.00-1.66; P = 0.05), a combined outcome of VT and CA (HR, 1.77; 95% CI, 1.10-2.84; P = 0.02) and all-cause mortality (HR, 1.27; 95% CI, 1.05-1.53; P = 0.01). All HRs adjusted. CONCLUSION: Among patients with STEMI, ICR was associated with an increased long-term risk of new-onset arrhythmia and all-cause mortality compared with CR.

KW - All-cause mortality

KW - Cardiac arrhythmia

KW - Complete revascularization

KW - Ischaemic heart disease

KW - Percutaneous coronary intervention

U2 - 10.1093/europace/euac242

DO - 10.1093/europace/euac242

M3 - Journal article

C2 - 36520640

AN - SCOPUS:85151573544

VL - 25

SP - 931

EP - 939

JO - Europace

JF - Europace

SN - 1099-5129

IS - 3

ER -

ID: 366522092